| Literature DB >> 36171786 |
Hongcheng Liu1, Hen Tian1,2, MingMing Jiang3, Tao Lin1, Ji Li1,2, Xiangzhong Huang2.
Abstract
The residues of cycloxaprid enantiomers and metabolites are investigated by ultraperformance liquid chromatography-high-resolution mass spectrometry (UPLC-HRMS) during raw and ripen Puer tea processing. A Chiralpak AG column with chiral stationary phase of amylose tris (3-chloro-5-methylphenylcarbamate) is succeed to separate the 1R, 2S-cycloxaprid, 1S, 2R-cycloxaprid, and their metabolite, which is identified as nitrylene-imidazolidine. It is not conversed 1R, 2S -cycloxaprid into 1S,2R-cycloxaprid during Puer tea processing. The estimated half-lives of the 1R,2S-cycloxaprid and 1S,2R-cycloxaprid are 0.97 and 1.1 h, respectively, and 1R,2S-cycloxaprid decreases more quickly than the 1S,2R-cycloxaprid. During raw Puer tea processing, the half-lives of 1R, 2S-cycloxaprid and 1S, 2R-cycloxaprid are 1.68 h and 1.77 h, but the residue is still detected even if it is over 730 day. However, the half-lives of 1R,2S -cycloxaprid and 1S,2R-cycloxaprid are 0.60 day and 0.63 day during ripen tea processing. The amounts of metabolite are more in raw tea than in ripen tea; the terminal residues are still detected until 730 days during raw tea. A significant enantioselectivity of 1R, 2S-cycloxaprid and 1S, 2R-cycloxaprid is observed during raw tea or ripen tea processing. The degration result shows the enantioselectivity of cycloxaprid in raw or ripen Puer tea processing.Entities:
Keywords: cycloxaprid; enantioselectivity; metaboliteLC‐HFMS; puer tea processing
Year: 2022 PMID: 36171786 PMCID: PMC9469841 DOI: 10.1002/fsn3.2901
Source DB: PubMed Journal: Food Sci Nutr ISSN: 2048-7177 Impact factor: 3.553
FIGURE 1typical LC‐HRMS chromatograms of metabolite and the transformation of cycloxaprid
Limits of detection, quantification, calibration equation
| LOD (µg /kg) | LOQ (µg /kg) | Calibration equation ( | Determination coefficient, | Linear range tested (µg/L) | |
|---|---|---|---|---|---|
|
| 0.2 | 1 | y = 62137x +7289 | 0.998 | 0.2–50 |
|
| 0.2 | 1 | y = 24244x −2547 | 0.999 | 0.2–50 |
| 2‐Chloro−5‐[[−2‐(nitromethylidene) imidazodin−1‐yl] methyl] pyridine | 0.1 | 1 | y = 34769x +1781 | 0.998 | 0.05–10 |
The recovery and RSD of an analyses spiked in Puer tea at two concentration (n = 6)
| Enantiomer | Addition (µg/kg) | Raw Puer tea | Ripen Puer tea | ||
|---|---|---|---|---|---|
| Recovery % | RSD % | Recovery % | RSD % | ||
|
| 10 | 93.2 | 6.8 | 94.7 | 6.2 |
| 1 | 88.4 | 2.8 | 84.6 | 4.6 | |
|
| 10 | 90.6 | 8.6 | 98.2 | 3.6 |
| 1 | 85.2 | 5.7 | 95.1 | 4.7 | |
| 2‐Chloro−5‐[[−2‐(nitromethylidene) imidazodin−1‐yl] methyl] pyridine | 10 | 88.7 | 3.8 | 86.3 | 5.5 |
| 1 | 84.9 | 4.1 | 82.5 | 3.9 | |
FIGURE 2Dissipation kinetic of optical pure compounds (a) 1R, 2S‐cycloxaprid, (b) 1S, 2R‐cycloxaprid and increase of metabolite
FIGURE 3Dissipation kinetics of enantiomerical cyxloxaprid at two divide stages in raw Puer tea: (a) 24 h; (b) 730 days
FIGURE 4The change of stereoselectivity (EF) in raw Puer tea processing
FIGURE 5Dissipation kinetics of enantiomerical cycloxaprid during ripen Puer tea processing
FIGURE 6The change of stereoselectivity (EF) in ripen Puer tea processing
FIGURE 7Dissipation kinetics of metabolite in Puer tea processing (a) raw Puer tea (b) ripen Puer tea